Literature DB >> 1672601

Respiratory function in the elderly and the effects of beta blockade.

A E Tattersfield1.   

Abstract

Bronchoconstriction, the main respiratory side effect from beta-blocking drugs, can be severe and precipitous in patients with asthma, but at most is very minor in patients with chronic bronchitis. Elderly patients with asthma and chronic bronchitis appear to run a similar risk from beta-blocking drugs as younger patients with these conditions, though there are no direct comparisons. Several studies have looked at the response of elderly patients to beta-blocking drugs, and the profile and incidence of respiratory side effects has been similar to those seen in studies of younger subjects. There is a greater danger in the elderly that a past history of asthma may be overlooked or that bronchoconstriction from a beta-blocking drug is attributed to other causes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672601     DOI: 10.1007/bf00114225

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  28 in total

1.  Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease.

Authors:  L A Nordstrom; F MacDonald; F L Gobel
Journal:  Chest       Date:  1975-03       Impact factor: 9.410

2.  A comparison of four beta-adrenoceptor antagonists in patients with asthma.

Authors:  M K Benson; W T Berrill; J M Cruickshank; G S Sterling
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

3.  The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics.

Authors:  H Formgren
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

4.  Arterial oxygen tension in relation to age in healthy subjects.

Authors:  C A Sorbini; V Grassi; E Solinas; G Muiesan
Journal:  Respiration       Date:  1968       Impact factor: 3.580

5.  Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter study.

Authors:  J Wikstrand; G Westergren; G Berglund; D Bracchetti; A Van Couter; C A Feldstein; K S Ming; K Kuramoto; S Landahl; E Meaney
Journal:  JAMA       Date:  1986-03-14       Impact factor: 56.272

6.  Do elderly patients respond differently to treatment with Moducren?

Authors:  W J Currie; M J Vandenburg; W D Cooper
Journal:  Br J Clin Pract       Date:  1984-03

7.  Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.

Authors:  W H Perks; S S Chatterjee; R S Croxson; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

8.  beta-Adrenoceptor blockade and pulmonary function in patients suffering from chronic obstructive lung disease.

Authors:  C L van Herwaarden
Journal:  J Cardiovasc Pharmacol       Date:  1983       Impact factor: 3.105

9.  Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.

Authors:  C M Hawkins; D W Richardson; P S Vokonas
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

10.  Influence of age on response to ipratropium and salbutamol in asthma.

Authors:  M I Ullah; G B Newman; K B Saunders
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

View more
  7 in total

1.  Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.

Authors:  Robinson Joannides; Nicholas Moore; Michaela Iacob; Patricia Compagnon; Guy Lerebours; Jean-François Menard; Christian Thuillez
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

Review 2.  Cardioselective beta-blockers for chronic obstructive pulmonary disease.

Authors:  S Salpeter; T Ormiston; E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 3.  Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.

Authors:  S Sulfi; A D Timmis
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503

4.  Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.

Authors:  Qingxia Du; Yongchang Sun; Ning Ding; Lijin Lu; Ying Chen
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

Review 5.  Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.

Authors:  Khaled Albouaini; Mohammed Andron; Albert Alahmar; Mohaned Egred
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

6.  Concomitant administration of simvastatin with ivabradine in contrast to metoprolol intensifies slowing of heart rate in normo- and hypercholesterolemic rats.

Authors:  Jacek Owczarek; Magdalena Jasińska; Jarosław Drożdż; Daria Orszulak-Michalak
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

7.  Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats.

Authors:  Fernanda C Silva; Franciny A Paiva; Flávia C Müller-Ribeiro; Henrique M A Caldeira; Marco A P Fontes; Rodrigo C A de Menezes; Karina R Casali; Gláucia H Fortes; Eleonora Tobaldini; Monica Solbiati; Nicola Montano; Valdo J Dias Da Silva; Deoclécio A Chianca
Journal:  Front Physiol       Date:  2016-07-26       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.